{"id":"https://openalex.org/W1965040871","doi":"https://doi.org/10.3892/or.14.2.401","title":"Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer","display_name":"Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer","publication_year":2005,"publication_date":"2005-08-01","ids":{"openalex":"https://openalex.org/W1965040871","doi":"https://doi.org/10.3892/or.14.2.401","mag":"1965040871","pmid":"https://pubmed.ncbi.nlm.nih.gov/16012722"},"language":"en","primary_location":{"id":"doi:10.3892/or.14.2.401","doi":"https://doi.org/10.3892/or.14.2.401","is_oa":false,"landing_page_url":"https://doi.org/10.3892/or.14.2.401","pdf_url":null,"source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038458213","display_name":"Yoshinori Nio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169016828","display_name":"Shimane University","ror":"https://ror.org/01jaaym28","country_code":"JP","type":"education","lineage":["https://openalex.org/I169016828"]},{"id":"https://openalex.org/I3129591023","display_name":"University of Shimane","ror":"https://ror.org/04m42eq84","country_code":"JP","type":"education","lineage":["https://openalex.org/I3129591023"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshinori Nio","raw_affiliation_strings":["Department of Cardiovascular and Digestive Surgery, Shimane University School of Medicine, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan. fsurgery@med.shimane-u.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular and Digestive Surgery, Shimane University School of Medicine, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan. fsurgery@med.shimane-u.ac.jp","institution_ids":["https://openalex.org/I169016828","https://openalex.org/I3129591023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061325623","display_name":"Koji Hashimoto","orcid":"https://orcid.org/0000-0002-8854-2810","observed_orcids":["https://orcid.org/0000-0002-8854-2810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koji Hashimoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111700491","display_name":"Seiji Yano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seiji Yano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000182211","display_name":"Masayuki Itakura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masayuki Itakura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080200760","display_name":"Makoto Koike","orcid":"https://orcid.org/0000-0003-2386-5560","observed_orcids":["https://orcid.org/0000-0003-2386-5560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Makoto Koike","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109537352","display_name":"Kazushige Yamaguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazushige Yamaguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113537060","display_name":"Shinichiro ENDO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shinichiro Endo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039122298","display_name":"Munechika Tsuji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Munechika Tsuji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112308285","display_name":"Tetsuya Higami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tetsuya Higami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037811939","display_name":"Riruke Maruyama","orcid":"https://orcid.org/0000-0002-8063-7284","observed_orcids":["https://orcid.org/0000-0002-8063-7284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riruke Maruyama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1723,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.56707368,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"14","issue":"2","first_page":"401","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8140000104904175},{"id":"https://openalex.org/keywords/recurrent-pancreatic-cancer","display_name":"recurrent pancreatic cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/advanced-pancreatic-cancer","display_name":"advanced pancreatic cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9290000200271606},{"id":"https://openalex.org/keywords/low-dose-gemcitabine","display_name":"low-dose gemcitabine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/tegafur-uracil","display_name":"tegafur-uracil","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9729999899864197},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6769999861717224},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8840000033378601},{"id":"https://openalex.org/keywords/clinical-benefit-response","display_name":"clinical benefit response","score":0.6809999942779541},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.871999979019165},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.722000002861023},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8814790844917297},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7089410424232483},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5797882080078125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5796595215797424},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5587525963783264},{"id":"https://openalex.org/C2777299880","wikidata":"https://www.wikidata.org/wiki/Q413370","display_name":"Tegafur","level":3,"score":0.5506375432014465},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.479979008436203},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47175389528274536},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4505978226661682},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4422692656517029},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4388018846511841},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.41679155826568604},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40036559104919434},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38532882928848267}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003248","descriptor_name":"Constipation","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007970","descriptor_name":"Leukopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011878","descriptor_name":"Radiotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3892/or.14.2.401","doi":"https://doi.org/10.3892/or.14.2.401","is_oa":false,"landing_page_url":"https://doi.org/10.3892/or.14.2.401","pdf_url":null,"source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},{"id":"pmid:16012722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16012722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology reports","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2412662850","https://openalex.org/W1985541721","https://openalex.org/W2255728954","https://openalex.org/W2988689375","https://openalex.org/W2260843134","https://openalex.org/W2415776144","https://openalex.org/W2070780256","https://openalex.org/W1965246454","https://openalex.org/W2467783240","https://openalex.org/W2282258681"],"abstract_inverted_index":{"The":[0,56,76,112,145,173,197,233],"present":[1],"study":[2],"assessed":[3],"the":[4,117,125,134,151,206,231,243,258],"anti-tumor":[5],"effects":[6,154],"and":[7,27,37,72,93,122,142,150,159,192,205,220,242,255,274,288],"clinical":[8,126,286],"benefits":[9],"of":[10,43,109,230,262,291],"intravenous":[11],"(i.v.)":[12],"or":[13,49,86,267],"intra-arterial":[14],"(i.a.)":[15],"gemcitabine":[16],"(GEM)":[17],"at":[18,82,89,95,105,270],"low":[19,271],"dose":[20,108,164,174],"plus":[21],"oral":[22],"chemotherapy":[23],"with":[24,32,46,103,278,284],"uracil-tegafur":[25],"(UFT)":[26],"cyclophosphamide":[28],"(CPA)":[29],"in":[30,101,168,202,228,253,276],"combination":[31,102,277],"radiotherapy":[33],"(RT)":[34],"against":[35],"recurrent":[36,51],"advanced":[38,48],"pancreatic":[39,52],"cancers.":[40],"A":[41,224],"total":[42,107],"22":[44],"patients":[45,77,181,187,194],"15":[47,60],"7":[50],"cancer":[53],"were":[54,78,116,200,250],"enrolled.":[55],"target":[57],"lesions":[58],"included":[59,155],"primary":[61,113],"tumors,":[62],"9":[63],"liver":[64],"metastases,":[65],"3":[66],"local":[67],"recurrences,":[68],"1":[69,73],"lung":[70],"metastasis":[71],"pleural":[74],"effusion.":[75],"each":[79,162],"given":[80],"GEM":[81,184,190,269],"200-400":[83],"mg":[84],"weekly":[85],"biweekly,":[87],"UFT":[88,273],"300":[90],"mg/day":[91,97],"daily":[92],"CPA":[94,275],"50":[96],"every":[98],"other":[99],"day":[100],"RT":[104,279],"a":[106,281],"40-60":[110],"Gy.":[111],"efficacy":[114],"measures":[115],"overall":[118,207],"response":[119,128],"rate":[120,246],"(RR)":[121],"survival.":[123],"Furthermore,":[124],"benefit":[127],"(CBR)":[129],"was":[130,147,166,178,209,226,237,247],"classified":[131],"by":[132],"measuring":[133],"pain":[135],"intensity,":[136],"analgesic":[137],"consumption,":[138],"Karnofsky":[139],"performance":[140],"status":[141],"body":[143],"weight.":[144],"regimen":[146,283],"well":[148],"tolerated,":[149],"major":[152],"side":[153,171,176],"anorexia,":[156],"general":[157],"malaise":[158],"myelo-suppression.":[160],"In":[161,264],"case,":[163],"reduction":[165],"effective":[167],"resolving":[169],"these":[170],"effects.":[172],"limiting":[175],"effect":[177],"thrombocytopenia.":[179],"Eleven":[180],"received":[182,188,195],"i.v.":[183,266],"alone,":[185],"6":[186,217],"i.a.":[189,268],"alone":[191],"5":[193],"both.":[196],"objective":[198],"responses":[199],"evaluated":[201],"all":[203],"patients,":[204],"RR":[208,254],"27%":[210],"(2":[211],"complete":[212],"responses,":[213,216],"4":[214],"partial":[215],"stable":[218],"diseases":[219],"10":[221],"progressive":[222],"diseases).":[223],"CBR":[225],"experienced":[227],"22.7%":[229],"patients.":[232],"mean":[234],"survival":[235,245,256],"period":[236],"10.6":[238],"months":[239],"(2-20":[240],"months),":[241],"1-year":[244],"42.2%.":[248],"There":[249],"no":[251],"differences":[252],"among":[257],"different":[259],"administration":[260],"methods":[261],"GEM.":[263],"conclusion,":[265],"dose,":[272],"is":[280,289],"well-tolerated":[282],"beneficial":[285],"efficacy,":[287],"worthy":[290],"further":[292],"study.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}